BIOMAT Database Logo BIOMAT Database Logo

[The treatment of bladder cancer with Bacillus Calmette Guerin (BCG)]. 1985

S Meretyk, and D Pode, and A Shapiro

UI MeSH Term Description Entries
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

S Meretyk, and D Pode, and A Shapiro
Bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer.
July 1995, Annals of the Academy of Medicine, Singapore,
S Meretyk, and D Pode, and A Shapiro
Bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer.
July 1997, International journal of oncology,
S Meretyk, and D Pode, and A Shapiro
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer.
May 2024, Biochimica et biophysica acta. Reviews on cancer,
S Meretyk, and D Pode, and A Shapiro
SAPHO syndrome with bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer.
August 2010, BMJ case reports,
S Meretyk, and D Pode, and A Shapiro
Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer.
January 1994, Comprehensive therapy,
S Meretyk, and D Pode, and A Shapiro
Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer.
March 2021, Current opinion in urology,
S Meretyk, and D Pode, and A Shapiro
Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment.
May 1998, The Australian and New Zealand journal of surgery,
S Meretyk, and D Pode, and A Shapiro
Bacillus Calmette-Guerin (BCG) endophthalmitis.
January 1988, Retina (Philadelphia, Pa.),
S Meretyk, and D Pode, and A Shapiro
BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer.
June 2002, Surgical oncology,
S Meretyk, and D Pode, and A Shapiro
Bacillus Calmette-Guerin and bladder cancer.
October 2007, Asian journal of surgery,
Copied contents to your clipboard!